The overall goal of the Tetramer Core is to develop and provide HLA Class I/peptide tetramers for use by Program Project Investigators in Projects 1, 2, 3 that examine the induction and maintenance of virus- specific CD8+ T cell-mediated immunity in humans across the age spectrum. Recently, the laboratories of Davis and McMichael have pioneered technological advances that allow the direct detection, quantitation, and isolation of antigen-specific T cells in the peripheral blood by using a fluorescent-labeled tetrameric complex of components consisting of MHC Class I alpha chain, beta2-microgolubin, and an antigenic peptide (HLA Class I/Peptide Tetramers). Individual HLA Class I-peptide tetramers must be generated for each antigen peptide to be studied at present, the availability of HLA Class I-peptide tetramers is extremely limited We therefore propose to apply or experience in the construction of the HLA Class I/HIV-1 peptidramers to the construction of tetramers for use by Program Project investigators in their studies of virus-specific CD8+ T cell immunity in human viral infections. Tetramer Core personnel will be responsible for the generation and distribution of tetramers. The generation of tetramers for Program Project Investigators will be prioritized based on identified epitopes and the distribution of HLA Class I alleles in the populations under study. The availability of this new technology to Program Project investigators should greatly enhance their ability to enumerate, isolate, and characterize virus-specific CD8+ T cells in human viral infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI049320-02
Application #
6588097
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Weiss, Eric R; Lamers, Susanna L; Henderson, Jennifer L et al. (2018) Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection. J Virol 92:
Song, InYoung; Gil, Anna; Mishra, Rabinarayan et al. (2017) Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope. Nat Struct Mol Biol 24:395-406
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210
Weiss, Eric R; Alter, Galit; Ogembo, Javier Gordon et al. (2017) High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. J Virol 91:
Aslan, Nuray; Watkin, Levi B; Gil, Anna et al. (2017) Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires. MBio 8:
Gil, Anna; Yassai, Maryam B; Naumov, Yuri N et al. (2015) Narrowing of human influenza A virus-specific T cell receptor ? and ? repertoires with increasing age. J Virol 89:4102-16
Gil, Anna; Kenney, Laurie L; Mishra, Rabinarayan et al. (2015) Vaccination and heterologous immunity: educating the immune system. Trans R Soc Trop Med Hyg 109:62-9
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Renzette, Nicholas; Somasundaran, Mohan; Brewster, Frank et al. (2014) Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids. J Virol 88:3744-55
Chen, Alex T; Cornberg, Markus; Gras, Stephanie et al. (2012) Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. PLoS Pathog 8:e1002633

Showing the most recent 10 out of 38 publications